发明名称 |
NEUTROPHIL ACTIVATION BY IMMUNE RESPONSE MODIFIER COMPOUNDS |
摘要 |
The invention provides a method of activating neutrophils. Generally, the method includes contacting neutrophils with a neutrophil-activating IRM compound and/or aTLR8-selective agonist in an amount effective to activate the neutrophils. In some embodiments, the method may be used to treat a condition treatable by activating neutrophils. In another aspect, the invention provides pharmaceutical compositions that generally include a neutrophil-activating IRM compound and/or a TLR8-selective agonist, or a pharmaceutically acceptable form thereof, in an amount effective to activate neutrophils. |
申请公布号 |
WO2005041891(A2) |
申请公布日期 |
2005.05.12 |
申请号 |
WO2004US36351 |
申请日期 |
2004.11.01 |
申请人 |
3M INNOVATIVE PROPERTIES COMPANY |
发明人 |
TOMAI, MARK A.,;VASILAKOS, JOHN P.,;WIGHTMAN, PAUL D., |
分类号 |
A61K;A61K38/00;C12N5/0787 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|